Ask almost any CFA® charterholder, and they’ll tell you: Level II is where things get serious. It’s often considered the hardest of the three exams, and the prep course that got you through Level I ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion Pharmaceuticals announced positive Phase 1b/2 results from its ongoing TUPELO trial ...

January 16, 2026 Studio 2 Extra: CCP’s new president Dr. Alycia Marshall After losing her son, commencement became healing. “That day, I saw all my children graduate,” Dr. Alycia Marshall, president ...

Salt Lake City, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, ...